Pharming Group NV - ADRPHAR
13F holders, Q1 2025 (March 31)4holders −1
1new positions
3sold out
$8.37avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding Pharming Group NV - ADR (PHAR) in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 3 sold out. The largest holders were Silverberg Bernstein Capital Management LLC ($402K), Morgan Stanley ($24K) and Nalls Sherbakoff Group, LLC ($7K).
- Company
- Pharming Group NV - ADR
- CUSIP
- 71716E105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $887 |
| Exits | 3 | $5K |
All 13F filers, Q4 2024 → Q1 2025: 406 shares bought and 504 shares sold, net −98 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Silverberg Bernstein Capital Management LLC | 0.37% | No change | 47,997 | $402K |
| Morgan Stanley | 0.00% | Add +11.5% | 2,900 | $24K |
| Nalls Sherbakoff Group, LLC | 0.01% | — | 870 | $7K |
| Coldstream Capital Management Inc. | 0.00% | New | 106 | $887 |
"% of holder's portfolio" is PHAR's weight in each manager's 13F, not the share of Pharming Group NV - ADR the manager owns.